VENUE PARTNER

OCTOBER 10, 2017

#PxHealth

CAMPUS BIOTECH CHEMIN DES MINES 9

1202 GENEVA, SWITZERLAND

@EventsPOLITICO @letemps

Photography and filming:There will be photography and/or filming at this event and your image may be captured by us and used for our business and promotional purposes in print or on our website. By registering for the event, you are giving us your permission to use your image in this way. If you have any queries about this, however, please email events@politico.eu.

Supporting Organizations:

Sli.do: An interactive event! We are excited to use Sli.do, an event app to boost your Health Care Summit experience through interactive elements such as Live Q&A, Polls and Twitter discussion! Visit Sli.do and enter code #PxHealth to take our first poll and submit any questions you may have for the speakers and moderators.

Wifi USERNAME: POLITICOHealthCareSummit Wifi PASSWORD: POLITICOAHCS2017

AGENDA

8:30 AM COFFEE AND REGISTRATION

9:00 AMCHAIRMANS’ WELCOME REMARKS• Christian Oliver, Senior Policy Editor, overseeing health care, POLITICO• Olivier Dessibourg, Science Correspondent, LE TEMPS

9:05 AM ABOUT CAMPUS BIOTECH• Benoît Dubuis, Director, FONDATION CAMPUS BIOTECH GENEVA

9:10 AM OPENING REMARKS • Gilles Pluntz, Senior Vice-President, Europe and Canada, FERRING

9:15 AM

Q&A - INSIGHTS ON THE WHO’S NEW STRATEGYModerated by Sarah Wheaton, Senior Health Reporter, POLITICO

• Peter Singer, Senior Advisor to Director General, WORLD HEALTH ORGANIZATION

9:30 AM

PANEL DISCUSSION - A GLOBAL MARKET MODEL FOR ACCESS TO MEDICINESModerated by Christian Oliver, Senior Policy Editor, POLITICO

• Thomas Bombelles, Head, Non-Governmental Organizations and Industry Relation Section, WORLD INTELLECTUAL PROPERTY ORGANIZATION• Peter Braun, Head of Global Access Strategy and Health Policy, ROCHE• Karl Brauner, Deputy Director-General, WORLD TRADE ORGANIZATION• Alexander Natz, Secretary General, EUCOPE

10:10 AM SPEED NETWORKING SESSION

10:30 AM REFRESHMENTS AND NETWORKING

10:50 AM

PANEL DISCUSSION - FAIR DRUG PRICINGModerated by Carmen Paun, Reporter, POLITICO

• José Inácio Faria MEP (EPP), Member on the Environment, Public Health and Food Safety Committee, EUROPEAN PARLIAMENT• Fumie Griego, Assistant Director-General, INTERNATIONAL FEDERATION OF PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS• Nina Renshaw, Secretary-General, EUROPEAN PUBLIC HEALTH ALLIANCE• Pascal Strupler, Director-General, SWISS FEDERAL OFFICE OF PUBLIC HEALTH

AGENDA

11:30 AM

PANEL DISCUSSION - PREVENTION AND PATIENT ENGAGEMENTModerated by Olivier Dessibourg, Science Correspondent, LE TEMPS

• Daciana Sârbu MEP (S&D), Vice-Chair of Committee on the Environment, Public Health and Food Safety, EUROPEAN PARLIAMENT• Nicola Bedlington, Secretary-General, EUROPEAN PATIENTS’ FORUM• Mihaela Militaru, Senior Director, EU Patient Advocacy & Strategic Partnerships, Oncology, MERCK• Päivi Sillanaukee, Permanent Secretary, Ministry of Social Affairs and Health, FINLAND

12:10 PM

FIRESIDE CHAT - ANTIMICROBIAL RESISTANCEModerated by Sarah Wheaton, Senior Health Reporter, POLITICO

• Sally Davies, Chief Medical Officer, UNITED KINGDOM

12:25 PM

NETWORKING LUNCH INTRODUCTORY REMARKS - TELEHEALTH DEPLOYMENT IN EUROPE: WHEN POLICY-MAKING SHAPES COUNTRY MATURITY

• Patricia Alegre, Global Market Access Director, AIR LIQUIDE HEALTHCARE

12:30 PM NETWORKING LUNCH

1:45 PM

PANEL DISCUSSION - THE ROAD AHEAD FOR SDGs: HEALTH AGENDA FOR 2030Moderated by Carmen Paun, Reporter, POLITICO Opening interview:• Vytenis Andriukaitis, Commissioner for Health and Food Safety, EUROPEAN COMMISSION

Panel discussion:• Vytenis Andriukaitis, Commissioner for Health and Food Safety, EUROPEAN COMMISSION• Ilona Kickbusch, Director, Global Health Centre and Adjunct Professor, GRADUATE INSTITUTE OF INTERNATIONAL AND DEVELOPMENT STUDIES• David Nabarro, Sustainable Development Facilitator and former UN Secretary General’s Special Adviser on Sustainable Development and Climate Change• Mark Pearson, Deputy Director of Employment, Labor and Social Affairs, ORGANIZATION FOR ECONOMIC COOPERATION AND DEVELOPMENT

2:40 PM

PANEL DISCUSSION - HEALTH VALLEY: BIOTECH INNOVATION AND ITS IMPACT ON HEALTH CAREModerated by Christian Oliver, Senior Policy Editor, POLITICO

Opening interview:• Helene Hellmark Knutsson, Minister for Higher Education and Research, SWEDEN

Panel discussion:• Helene Hellmark Knutsson, Minister for Higher Education and Research, SWEDEN• Henry Markram, Founder and Director, BLUE BRAIN PROJECT• Line Matthiessen, Acting Director of the Health Directorate, DG Research and Innovation, EUROPEAN COMMISSION

3:20 PM REFRESHMENTS AND NETWORKING

3:40 PM

PANEL DISCUSSION - TECHNOLOGY: THE PATH FOR INCREASED ACCESS TO HEALTH CAREModerated by Olivier Dessibourg, Science Correspondent, LE TEMPS

• Ain Aaviksoo, Deputy Secretary General for E-services and Innovation, Ministry of Social Affairs, ESTONIA• Bruno de Oliveira Alves, Policy Advisor, DG CONNECT, EUROPEAN COMMISSION • Felix Frauendorf, Co-Founder and Managing Director, AURORA HEALTH

4:15 PM

SPOTLIGHT SESSION - PRIORITIZING WOMEN’S HEALTH Moderated by Sarah Wheaton, Senior Health Reporter, POLITICO • Sohier Elneil, Chair of the Board of Trustees, FORWARD and Consultant in Urogynaecology, UNIVERSITY COLLEGE OF LONDON, INSTITUTE OF WOMEN’S HEALTH• Sinéad Hewson, Member of the Board, EUROPEAN INSTITUTE OF WOMEN’S HEALTH

4:45 PM

CHAIRMANS’ CLOSING REMARKS • Christian Oliver, Senior Policy Editor, overseeing health care, POLITICO• Olivier Dessibourg, Science Correspondent, LE TEMPS

SPEAKERS

VYTENIS ANDRIUKAITIS @V_AndriukaitisCOMMISSIONER FOR HEALTH AND FOOD SAFETY, EUROPEAN COMMISSION

Vytenis Andriukaitis was appointed European Commissioner for Health and Food Safety in November 2014. Before, he served as Lith-uania’s Health Minister from 2012 to 2014. He was a Member of the Lithuanian Parliament for a total of six mandates, serving from 2008 to 2014 and from 1992 to 2004. During this time, he led the Lithuanian delegation to the Convention on the Future of Europe and served as Deputy Chairman of the Committee on European Affairs. He was one of the co-authors of the 1992 Constitution, and a signatory of Lithuania’s independence act. He was also one of the founders of the Lithuani-an Social-Democratic party, and in 1990 was elected to the Supreme Council of the Republic of Lithuania, which preceded the Lithuanian Parliament. He graduated from the Kaunas Institute of Medicine and was a practicing surgeon for more than 20 years. He also holds a degree in History from Vilnius University.

HELENE HELLMARK KNUTSSON @helenehkMINISTER FOR HIGHER EDUCATION AND RESEARCH, SWEDEN

Helene Hellmark Knutsson has been Minister for Higher Education and Research of Sweden since 2014. She is also a politician in the Swedish Social Democratic Party. Hellmark Knutsson was formerly an ombuds-man in the Swedish Trade Union Confederation, as well as a Municipal Commissioner and Mayor of the Municipality of Sundbyberg. Along with other assignments and positions as a board member and chair, Hellmark Knutsson has also been a County Council Commissioner and group leader of the Swedish Social Democratic Party at Stockholm County Council.

JOSÉ INÁCIO FARIA @JoseFariaMEPMEP, MEMBER ON THE ENVIRONMENT, PUBLIC HEALTH AND FOOD SAFETY COMMITTEE, EUROPEAN PARLIAMENT

José Inácio Faria is a Member of the European Parliament and Portu-guese Partido da Terra, part of the European People’s Party. He was elected to the European Parliament in 2014 and sits on several com-mittees, including the Committee on the Environment, Public Health and Food Safety (ENVI). He is a member of the MEP Interest Group “European Patients’ Rights and Cross-Border Healthcare.” Before his election to the European Parliament, Faria provided legal and political support to the Partido da Terra at the Lisbon Municipal Assembly. From 2009 to 2011, he served as Secretary General of the Partido da Terra and from 2007 to 2009, he was the Partido da Terra’s Chair of the National Jurisdiction Council. Faria is a lawyer and graduated from the Universi-ty of Cáceres.

DACIANA SÂRBU @DacianaSarbu MEP, VICE-CHAIR OF THE ENVIRONMENT, PUBLIC HEALTH AND FOOD SAFETY COMMITTEE, EUROPEAN PARLIAMENT

Daciana Sârbu is a Member of the European Parliament and Romanian Social Democratic Party (PSD), part of the Group of the Progressive Alli-ance of Socialists and Democrats in the European Parliament (S&D). She is vice-chair of the European Parliament’s Committee on the Environ-ment, Public Health and Food Safety (ENVI). Some of her main priorities include child nutrition and the fight against obesity. She co-authored a European Parliament resolution, calling for a legal limit on industrial trans fatty acids in food and she supports legislation to minimize chil-dren’s exposure to advertising for unhealthy foods and alcohol.

SPEAKERS

AIN AAVIKSOO @ainaaviksooDEPUTY SECRETARY GENERAL FOR E-SERVICES AND INNOVATION, MINISTRY OF SOCIAL AFFAIRS, ESTONIA

Ain Aaviksoo is Deputy Secretary General for E-services and Innovation at the Ministry of Social Affairs in Estonia, overseeing digital transfor-mation and innovation of social security in Estonia, including health, labor, and social matters. Aaviksoo also chairs the mHealth working group of the European Commission’s eHealth Network and lectures at the Tallinn University of Technology and the Medical Faculty of the University of Tartu. He has earlier work experience as a physician, sen-ior civil servant, health-tech entrepreneur, an international consultant on large system transformation and technology adoption in health care, and as CEO of public policy think-tank, Praxis. He has published over 20 peer-reviewed articles and contributed several book chapters on health policy and e-health. Aaviksoo obtained an MD from the Uni-versity of Tartu and an MPH from Harvard University.

NICOLA BEDLINGTON @NABedlingtonSECRETARY-GENERAL, EUROPEAN PATIENTS’ FORUM

Nicola Bedlington joined the European Patients’ Forum as its first Executive Director in 2006 and became Secretary-General in 2014. In this capacity, she is the Coordinator of the European Patient Academy on Therapeutic Innovation (EUPATI). From 2004 to 2006, she worked for the Swiss Government, leading the Environment and Schools Initia-tives Secretariat (ENSI). From 1996 to 1999, Bedlington was the founding Director of the European Disability Forum, an umbrella organization uniting over 70 European disability NGOs and National Councils of Disabled People to advocate for the rights and inclusion of disabled citizens. From 1991 to 1996, she led the NGO unit in the HELIOS Pro-gramme, a European Commission Action Programme promoting equal opportunities for disabled people. In Switzerland, she also worked as an independent consultant and evaluator, specializing in European social and development policy and health advocacy. Bedlington studied business and human resource management in the U.K. and France.

THOMAS BOMBELLES @WIPOHEAD, NON-GOVERNMENTAL ORGANIZATIONS AND INDUSTRY RELATION SECTION, WORLD INTELLECTUAL PROPERTY ORGANIZATION Thomas Bombelles is Head of the Non-Governmental Organizations and Industry Relation Section at the World Intellectual Property Organization (WIPO) in Geneva, Switzerland. Prior to joining WIPO, Bombelles worked in the pharmaceutical industry as an international policy analyst based in Washington D.C., working first for the Pharmaceutical Research and Manufacturers of America and subsequently for Merck & Co., Inc. He has a BA degree in English from the University of Michigan, Ann Arbor, and an MA degree in International Relations from the Johns Hopkins School of Advanced International Studies, Washington D.C.

PETER BRAUN @Roche HEAD OF GLOBAL ACCESS STRATEGY AND HEALTH POLICY, ROCHE

Peter Braun is Head of Global Access Strategy and Health Policy at Roche in Switzerland. Braun is responsible for leading global health policy, product communications and access strategy across the or-ganization. Braun’s career at Roche began in 1991 and has spanned a variety of global, regional and affiliate roles across developed as well as emerging countries (U.S., Mexico, Belgium, The Netherlands, and Peru). In his role as Lifecycle Leader of Herceptin and Tarceva, he led teams through multiple clinical study readouts, as well as two global regula-tory approvals. Prior to his current role, he worked as Roche’s General Manager of Peru. Braun holds an MBA from the European Institute of Business Administration (INSEAD) and undergraduate degrees from the University of Pennsylvania and the Wharton School of Business.

SPEAKERS

KARL BRAUNER @wtoDEPUTY DIRECTOR-GENERAL, WORLD TRADE ORGANIZATION

Karl Brauner has been Deputy Director-General of the World Trade Organization (WTO) since 2013. Before, he was Director-General for external economic policy at the German Federal Ministry of Economics, where he was Germany’s member in the European Union’s (EU) Trade Policy Committee, taking part in WTO ministerial conferences. As Direc-tor-General, he administered all the instruments of export promotion, export controls and all bilateral economic relations outside the EU. In Berlin, his responsibilities covered budget, human resources and general administration, including cabinet and parliamentary matters. He was involved in the Government move from Bonn to Berlin. He also worked at the German Mission to the United Nations in New York, Athens and Sydney. Brauner started his career in the legal department of the German Ministry of Economics. He is a lawyer, with degrees from Germany and Cambridge.

SALLY DAVIES @CMO_EnglandCHIEF MEDICAL OFFICER, UNITED KINGDOM

Sally Davies was appointed Chief Medical Officer for England and Chief Medical Advisor to the United Kingdom in 2010. She advises on medical matters with a particular focus on public health and providing leadership to public health directors. Before, she was the Department of Health’s Chief Scientific Advisor and Research Development lead. Davies has spent her career raising public awareness on Antimicro-bial Resistance (AMR). She chairs the World Health Organization AMR Strategic & Technical Advisory Group, and wrote a Penguin book and performed a TED Talk on the issue. In 2006, she founded the National Institute for Health Research. Davies is Fellow of the Royal Society and member of the National Academy of Medicine.

BRUNO DE OLIVEIRA ALVES @EU_Commission POLICY ADVISOR, DG CONNECT, EUROPEAN COMMISSION

Bruno Alves is Policy Advisor at the European Commission Directo-rate General for Communications Networks, Content and Technology (DG CONNECT), working on policy and research and innovation (R&I) initiatives promoting Information and Communications Technology (ICT). Before joining the European Commission, he was the head of Nike Inc.’s European Public Policy. During his time at Nike, he also served as elected President of the European Federation of the Sporting Goods Industry (FESI) and Board Member of leading European think-tank “Sport & Citizenship.” In 1998, he moved from the Council of Europe in Strasbourg to Brussels to join Ernst & Young and launch an advisory practice for the Technology, Communication and Entertainment (TCE) industries. He started his career at Portugal’s national public television and radio broadcaster (RTP) and has 20 years’ experience in interna-tional public policy having worked in Lisbon, London, Strasbourg and Brussels. Bruno holds a degree in European Community Law from King’s College University, London.

SOHIER ELNEIL @ElneilSuzy CHAIR OF THE BOARD OF TRUSTEES, FORWARD AND CONSULTANT IN UROGYNAECOLOGY, UNIVERSITY COLLEGE OF LONDON, INSTITUTE OF WOMEN’S HEALTH

Sohier Elneil is a Urogynaecologist Consultant and Gynaecologist at the University College Hospital and the National Hospital for Neurol-ogy and Neurosurgery in London. She started her career in the field of Urogynaecology in the early 1990’s when she became involved with patients who suffered vesicovaginal fistulas and female genital mutilation in under-resourced settings. This formed the basis of a career that started with gynaecology and went onto sub-specialization in female pelvic medicine and reconstructive surgery. Over the last decade, she has developed the field of neuro-urogynaecology. Her work involves both clinical and basic science research and collaborates with colleagues in the United Kingdom, Europe, America, Africa and Asia. Elneil has been awarded grants for her work on sensory mechanisms in the bladder, mechanism of action studies in neuromodulation, the role of chemo-neuromodulation in chronic pain states, obstetric fistula research, and female genital mutilation research.

SPEAKERS

FELIX FRAUENDORF @MoodpathAppCO-FOUNDER AND MANAGING DIRECTOR, AURORA HEALTH

Felix Frauendorf is co-founder and managing director of Aurora Health, a Berlin-based technology company developing digital solutions to im-prove the detection and treatment of mental health disorders. Before founding Aurora Health, Frauendorf worked for the company builder Hitfox Group in Berlin as group strategy manager. In this role he helped to start three new companies in the financial technology sector. Prior to Hitfox, Frauendorf spent two years in management consulting, focusing on the development of business steering models for interna-tional clients in the health care and specialty chemicals industry. He holds an MSc in international business and graduated with distinction from ESCP Europe Business School in Berlin and New Delhi.

FUMIE GRIEGO @IFPMAASSISTANT DIRECTOR-GENERAL, INTERNATIONAL FEDERATION OF PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

Fumie Griego was appointed Assistant Director-General for Strategic Planning, Policy and Research at the International Federation of Phar-maceutical Manufacturers & Associations (IFPMA) in early 2017. Griego leads IFPMA’s work on health economics and policy, such as the value of medicines, pricing and reimbursement, and metrics and evalua-tion. Prior to joining IFPMA, she was Head of Global Oncology Policy and Strategy, Global Government Affairs & Policy at Merck KGaA and Vice President for International Health Policy at the Pharmaceutical Research and Manufacturers of America (PhRMA). Before PhRMA, Griego was a senior economist at the White House Office of Management and Budget where she provided U.S. senior officials in both the Bush and Obama Administrations policy advice on a range of health policy issues. Griego holds a PhD in Health Policy from Harvard University and BA and MSc of Science degrees in Earth Systems from Stanford University.

SINÉAD HEWSON @sineadhewson MEMBER OF THE BOARD, EUROPEAN INSTITUTE OF WOMEN’S HEALTH

Sinéad Hewson is Board Member of the European Institute of Wom-en’s Health. She has a background in health and communications and works with clients on how gender and diversity can increase perfor-mance in teams, organizations, and society at large. Hewson also acts as a strategic advisor to the Women’s Business Initiative International, counseling on areas of women and entrepreneurship, and The Bijlmer project, helping people who have been trafficked to become independ-ent and rebuild their lives. She was a lecturer at Rotterdam University of Applied Sciences and is a PhD candidate.

ILONA KICKBUSCH @IlonaKickbusch DIRECTOR, GLOBAL HEALTH CENTRE AND ADJUNCT PROFESSOR, GRADUATE INSTITUTE OF INTERNATIONAL AND DEVELOPMENT STUDIES

Ilona Kickbusch is Director of the Global Health Centre and Adjunct Professor at the Graduate Institute of International and Development Studies in Geneva. Her specialties include global health governance, health security, public health, health promotion, health literacy and health in all policies. She is a senior advisor to the Regional Directors of the World Health Organization (WHO) Regional Offices for Europe and the Eastern Mediterranean and has advised many countries on their global health strategies. Kickbusch was recently awarded the Cross of the Order of Merit of the Federal Republic of Germany (Bundesverdien-stkreuz) in recognition of her contributions to innovation in govern-ance for global health and global health diplomacy. Kickbusch has been deeply involved in the development of the Health 2020 European health policy framework, and was previously a member of the inde-pendent Ebola interim assessment panel of the WHO. She has contrib-uted to innovation in health in many ways throughout her career and is strongly committed to the empowerment of women.

SPEAKERS

HENRY MARKRAM @HumanBrainProjFOUNDER AND DIRECTOR, BLUE BRAIN PROJECT

Henry Markram is Founder and Director of the Blue Brain Project, Director of the Center for Neuroscience & Technology, and Founder and Co-Director of Swiss Federal Institute of Technology’s (EPFL) Brain Mind Institute. Markram founded the Blue Brain Project in 2005, digitally reconstructing and simulating the brain on supercomputers. In 2011, he started forming a consortium of 112 universities and developed a proposal for the Human Brain Project to scale up to reconstructing and eventually simulating the human brain. In 2013, the Human Brain Project won a €1 billion euro grant for over 10 years from the European Commission. He finished school in 1980 at Kearsney College in South Africa, studied medicine and neuroscience at Cape Town University in 1988, obtained a PhD in neuroscience at the Weizmann Institute in 1991, completed postdoctoral work as a Fulbright Scholar at the Nation-al Institutes of Health (NIH) in 1992, and was a Minerva Fellow at the Max-Planck in 1994.

LINE MATTHIESSEN @EUScienceInnovACTING DIRECTOR, DG RESEARCH AND INNOVATION, EUROPEAN COMMISSION

Line Matthiessen is Acting Director of the Directorate for Health at the European Commission’s Directorate-General for Research and Innova-tion. Her responsibilities include providing overall strategic orienta-tion and management of the Health Research Directorate. She initiates and provides support for legislative, regulatory and policy issues in the area of health research and innovation, including intellectual property. Matthiessen is also the Head of Unit responsible for Fighting Infectious Diseases and Advancing Public Health. She previously served as Head of Unit for horizontal aspects and coordination in the Directorate for Biotechnologies, Agriculture and Food Research from 2007 to 2010. She is a member of the management board of the European Centre for Disease Control and sits on several advisory boards. Matthiessen was trained as an MD at the University of Odense, Denmark and received her PhD in Neurosciences from the University of Paris VI in 1993.

MIHAELA MILITARU @MerckHealthcare SENIOR DIRECTOR, EU PATIENT ADVOCACY & STRATEGIC PARTNERSHIPS, ONCOLOGY, MERCK

Mihaela Militaru is Senior Director of EU Patient Advocacy, Strategic Partnerships and Oncology at Merck. Before joining Merck in 2016, Militaru was Director of the European Cancer Patient Coalition (ECPC), a European umbrella organization of cancer patient associations, with over 408 members across the 28 European Union (EU) member states and beyond. Prior, she worked in EU affairs for 12 years, first as a liai-son officer of the Romanian Senate to the European Parliament for four years, and subsequently as a policy adviser at the European Parliament for eight years. During her final years in the European Parliament, she focused on health care policy, particularly on how to improve EU-level measures to fight diseases, such as cancer, multiple sclerosis and fibro-myalgia.

DAVID NABARRO @davidnabarro SUSTAINABLE DEVELOPMENT FACILITATOR AND FORMER UN SECRETARY GENERAL’S SPECIAL ADVISER ON SUSTAINABLE DEVELOPMENT AND CLIMATE CHANGE

David Nabarro is currently Sustainable Development Facilitator. He has over 40 years of experience in public health, nutrition, and develop-ment work at the national, regional and global levels, and has held positions in non-governmental organizations, universities, national governments and the United Nations. He is former Special Adviser to the United Nations Secretary-General on the 2030 Agenda for Sustain-able Development and Climate Change. Before, he served as Special Envoy of the Secretary-General on Ebola, providing strategic and policy direction for the international response. From 2011 to 2015, served as Coordinator of the Movement to Scale Up Nutrition. Nabarro holds an MA, MSc and a Medical degree from Oxford University. He also holds a Masters in Public Health from London University. He is a Fellow of the Royal College of Physicians, and in 1982 was appointed a Commander of the Most Excellent Order of the British Empire (CBE) in recognition of his international public service.

SPEAKERS

ALEXANDER NATZ @EUCOPESECRETARY GENERAL, EUCOPE

Alexander Natz is Secretary General of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and works as a lawyer for the firm, Novacos, in Dusseldorf. From 2008 to 2013, he was head of the German Pharmaceutical Industry Association’s (BPI) Brussels office. Be-fore, he worked at Sträter Law Firm in Germany, with a special focus on managed entry agreements, licensing and pharmaceuticals. Natz also worked in the field of competition law with the European Commission and in the pharmaceutical industry. As a research assistant at Duke University (USA), he has dealt with international pharmaceutical law. His doctorate was supervised by former judge at the European Court of Justice, Prof. Dr. Dr. Ulrich Everling.

MARK PEARSON @OECD_SocialDEPUTY DIRECTOR OF EMPLOYMENT, LABOR AND SOCIAL AFFAIRS, ORGANIZATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT

Mark Pearson is Deputy-Director for Employment, Labor and Social Affairs (ELS) at the Organization for Economic Co-operation and Development (OECD). He joined the organization in 1992 and has held various positions throughout his tenure. In 2009, he became Head of the Health Division where the central focus of work has been on how to deliver health care with greater efficiency, putting more effort into prevention of obesity and harmful use of alcohol. He gave evidence to the U.S. Senate on ‘Obamacare’, and has been on a panel advising the Chinese government on its health reforms. Prior to joining the OECD, Pearson worked for the Institute for Fiscal Studies in London, and as a consultant for the World Bank, the International Monetary Fund (IMF), and the European Commission. He has a degree in Politics, Philosophy and Economics from Oxford, and an MSc in Economics and Economet-rics from Birkbeck, University of London.

NINA RENSHAW @ninawren SECRETARY-GENERAL, EUROPEAN PUBLIC HEALTH ALLIANCE

Nina Renshaw joined the European Public Health Alliance (EPHA) as Secretary-General in late 2014 after eight years at Brussels-based en-vironmental group, Transport & Environment, where she was Deputy Director. She has campaigned on a variety of EU policies, including road safety and the health impacts of transport. She was a delegate to the World Health Organization (WHO) and the United Nations Econom-ic Commission for Europe (UNECE) and represented the Green10 envi-ronmental groups within the European Commission’s Advisory Group on red tape reduction. Renshaw represents EPHA on the Civil Society Contact Group, the Social Platform, the Better Regulation Watchdog, the Executive Committee of the Health and Environment Alliance, and is a member of the European Commission’s Advisory Group on the EU-US ’TTIP’ trade negotiations. Renshaw holds a degree in International Business in the U.K. and an MA in European Policy and Politics from Humboldt University in Berlin and Bath University, where she special-ized in civil society and policy-making.

PÄIVI SILLANAUKEE @PSillanaukee PERMANENT SECRETARY, MINISTRY OF SOCIAL AFFAIRS AND HEALTH, FINLAND

Päivi Sillanaukee has been Permanent Secretary of the Ministry of Social Affairs and Health of Finland since October 2012. She has held various development and management positions within public admin-istration. In her current role, Sillanaukee is responsible for directing, developing and monitoring the operations of the Ministry and its administrative branch. Previously, she was Director-General of the De-partment of Social and Health Services at the Ministry of Social Affairs and Health. Sillanaukee will serve as Finland’s representative to the World Health Organization’s Executive Board from 2018 to 2021.

SPEAKERS

PETER SINGER @PeterASingerSENIOR ADVISOR TO DIRECTOR GENERAL, WORLD HEALTH ORGANIZATION

Peter Singer is Senior Advisor to the Director General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus. He is also Chief Executive Officer of Grand Challenges Canada and Professor of Medicine at the University of Toronto. In 2011, Singer was appoint-ed an Officer of the Order of Canada for his contributions to health research and bioethics, and for his dedication to improving health in developing countries. In 2007, he received the Michael Smith Prize as Canada’s Health Researcher of the Year in Population Health and Health Services. He is a Fellow of the Royal Society of Canada, the Ca-nadian Academy of Health Sciences, the U.S. National Academy of Medi-cine, and The Academy of Sciences for the Developing World (TWAS).

PASCAL STRUPLER @BAG_INTDIRECTOR-GENERAL, SWISS FEDERAL OFFICE OF PUBLIC HEALTH

Pascal Strupler has been Director-General of the Swiss Federal Office of Public Health (FOPH) since 2010. In this role, he coordinates office business with departmental planning and ensures that the office, and in certain cases the Federal Department of Home Affairs (DHA), are rep-resented in important interdepartmental working groups, preparatory committees in Swiss parliament and in international bodies. He has a long career in public service, having held positions within the Federal Office for Foreign Economic Affairs, the Federal Department of Home Affairs, and the Swiss Embassy in Moscow. Strupler is a graduate of the University of Bern and the Swiss Graduate School of Public Administra-tion (IDHEAP).

BENOIT DUBUIS @CampusBiotech DIRECTOR, FONDATION CAMPUS BIOTECH GENEVA

Benoît Dubuis is Director of the Fondation Campus Biotech, Geneva. He has almost 20 years of international experience in the field of life sciences, both in industry and in research institutes. He has occu-pied different management positions in pharmaceutical companies, including Chemap, Ciba-Geigy/Novartis and Lonza. In 2004, he co-found-ed Eclosion, a Swiss Life Sciences seed-fund and incubator where he serves as Director. Dubuis joined the Ecole Polytechnique Fédérale de Lausanne (EPFL) in 2000 as Licensing Executive and adviser for the school management. He established the School of Life Sciences and served as its first Dean. He also launched the BioAlps organization and founded Excellgene SA. In addition to his professional activities, Dubuis contributes to different non-for-profit organizations support-ing the promotion and the understanding of Life Sciences. He serves as President of the BioAlps association and of the Swiss Life-Sciences Network Inartis and has published numerous articles and books in the field of Biotechnology, Life Sciences and Innovation.

VENUE PARTNER REMARKS

GILLES PLUNTZ @FerringNews SENIOR VICE-PRESIDENT, EUROPE AND CANADA, FERRING

Gilles Pluntz joined Ferring in March 2004. He is responsible for man-aging Ferring’s affiliates across the globe, including Russia, Central and Eastern Europe, Israel, and countries part of the Commonwealth of Independent States. Pluntz is also a member of the Research Development Marketing Committee (RDMC) at the group level. Before joining Ferring, Pluntz held a number of senior management positions throughout Europe, the Middle East and the USA during a 19-year career at Merck & Co. He graduated from Ecole des Mines de Paris in France and from Stanford University in California, USA.

PATRICIA ALEGRE @airliquidegroup GLOBAL MARKET ACCESS DIRECTOR, AIR LIQUIDE HEALTHCARE

A pharmacist with an MBA in health economics, Patricia Alegre has been Global Market Access Director at Air Liquide Healthcare since 2015, increasing patient access to high-value healthcare innovations. She has an expertise in health economics, pricing and evidence development at the international level from 20 years’ experience in pharmaceutical and medical device industries. She uses her expertise in identifying and articulating the clinical, humanistic and economic value of health technologies for stakeholders and particularly health care decision-makers. She is an active member of international and national expert communities through guidance publications and trainings, including ISPOR and Collège des Economistes de la Santé in France.

SPONSOR REMARKS

CHRISTIAN OLIVER @PepinBossu SENIOR POLICY EDITOR, OVERSEEING HEALTH CARE, POLITICO

Christian Oliver is POLITICO’s Senior Policy Editor. Immediately prior to joining POLITICO, Oliver worked for the Financial Times in Brussels, covering competition policy. He started his journalism career with Reu-ters in London in 2002 before being posted to Iran and Latin America. He joined the Financial Times as Korea correspondent in 2008 and was the newspaper’s deputy analysis editor from 2012 to 2014.

SARAH WHEATON @swheaton SENIOR HEALTH REPORTER, POLITICO

Sarah Wheaton is Senior Health Reporter for POLITICO. Prior to moving to Brussels, Wheaton was a White House correspondent for POLITICO in the United States, covering the final two years of the Obama administration, and a health care reporter for POLITICO Pro. She spent the first part of her career at The New York Times, where her reporting on breaking news, the 2008 and 2012 campaigns and the White House appeared online and in print. She grew up in Clearwater, Florida, and holds a bachelor’s degree in Political Communication from the George Washington University in Washington, D.C.

MODERATORS

CARMEN PAUN @carmenpaun REPORTER, POLITICO

Carmen Paun is a health care reporter for POLITICO, based in Brussels. Before joining POLITICO, she was a freelancer covering regulatory and international affairs out of the EU capital. She has reported on a wide range of topics, from money laundering to food production to chemi-cals, for media organizations such as International News Services and Chemical Watch. Paun also covered terrorism and foreign affairs as an English-language correspondent for France 24 and Radio France Inter-national (RFI), and had a stint as a CNN local producer during the 2015 Verviers terrorism case. Paun holds a bachelor degree in journalism and a bachelor degree in social communication and public relations from the University of Bucharest in Romania. During her student years, she worked for Campaign Romania, covering the country’s creative adver-tising and public relations industry.

OLIVIER DESSIBOURG @odessib SCIENCE CORRESPONDENT, LE TEMPS

Olivier Dessibourg is an award-winning science journalist and editor. For 12 years, until December 2016, he headed the Science section of the daily newspaper Le Temps, covering all fields from hard science to health and environmental issues.W A physicist, mathematician and science teacher by training, he is the President of the Swiss Association of Science Journalism SASJ (350 members), and the Swiss delegate to the World Federation of Science Journalism. Now freelance, his articles appear in Le Temps, New Scientist (U.K.), Le Monde and La Recherche (France).

MODERATORS

STAY AHEAD – Upcoming POLITICO Events

PARIS

• Thursday, November 30: Agriculture and Food Summit 2017, founding partner ECPA & presented by AB InBEV and YARA

• Thursday, February 8: Capital Markets Summit 2018, presented by Hogan Lovells

BRUSSELS

• Wednesday, October 11: Kickstarting Europe #1, powered by Telefónica

• Wednesday, October 11: Energy Visions Series #2 – What is the role of gas in the clean energy transition? Presented by Shell

• Tuesday, November 7: Outside, In: The Great Personalized Medicines Debate, presented by Philips

• Thursday, November 9: Playbook Breakfast with Maroš Šefčovič, European Commission Vice-President for Energy Union, presented by Iberdrola

• Thursday, November 23: Energy Visions Series #3 – Post COP23 – The Changing dynamics in climate and energy diplomacy. Presented by Shell

• Monday, December 4: Kickstarting Europe #2, powered by Telefónica

• Monday, December 4: Connected Transport Summit 2017

• Wednesday, December 6: POLITICO 28, presented by Merck

For more information on sponsorship & additional event opportunities, contact events@politico.eu.

To stay up to date with all upcoming programs, visit www.politico.eu/events/future-events.

Only one in fi ve employees self-identifi es as curious, our global study found. It’s the curious ones who engage with progress in science and technology.

Find out more facts about curiosity at work:

curiosity.merckgroup.com

CURIOUSMIND

MATTERS

Anzeigen_Economist_Merck_RZ.indd 3 21.12.16 10:57

Access to healthcare is a multi-dimensional challenge; specific to the country and local healthcare system. At Roche we are partnering with local stakeholders to develop tailored access solutions that really make a difference to people.

Ground-breaking advances in medicine are only meaningful when they reach the people who need them.

Only one in fi ve employees self-identifi es as curious, our global study found. It’s the curious ones who engage with progress in science and technology.

Find out more facts about curiosity at work:

curiosity.merckgroup.com

CURIOUSMIND

MATTERS

Anzeigen_Economist_Merck_RZ.indd 3 21.12.16 10:57

Access to healthcare is a multi-dimensional challenge; specific to the country and local healthcare system. At Roche we are partnering with local stakeholders to develop tailored access solutions that really make a difference to people.

Ground-breaking advances in medicine are only meaningful when they reach the people who need them.

Discover the richness of the Campus Biotech ecosystem, which is built around three values: innovation, collabora-tion, and translation. With innovation, we find new ways of doing things for the benefit of patient and population. With collaboration, we don’t duplicate e�orts, but capitalise on existing knowledge, promote synergies and secure impact. And with translation, we bring academia, entre-preneurship and industry together to create products and solutions that can save and improve lives.

Are you ready to become part of our ecosystem?www.campusbiotech.ch

Headquartered in Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets

innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics.

Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. To learn more about

Ferring or its products please visit www.ferring.com

MEDICINE ON THE BODY’S OWN TERMS

Ferring –for life

Discover the richness of the Campus Biotech ecosystem, which is built around three values: innovation, collabora-tion, and translation. With innovation, we find new ways of doing things for the benefit of patient and population. With collaboration, we don’t duplicate e�orts, but capitalise on existing knowledge, promote synergies and secure impact. And with translation, we bring academia, entre-preneurship and industry together to create products and solutions that can save and improve lives.

Are you ready to become part of our ecosystem?www.campusbiotech.ch

Headquartered in Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets

innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics.

Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. To learn more about

Ferring or its products please visit www.ferring.com

MEDICINE ON THE BODY’S OWN TERMS

Ferring –for life

BACK AT HOMEnever alone

© W

este

nd61

HH

C-00

8

www.chroniccareconnect.com

Telemonitoring based on criteria pre-de�ned with

the referral physician

Personalised support from quali�ed nurses who are speci�cally

trained in managing care plans and treatment

of the disease

Alerts generated by tracking algorithms,

individually managed by quali�ed

professionals

A REMOTE MONITORING SOLUTION TO SUPPORT YOUR PATIENTS WITH CHRONIC DISEASES

PROVEN RESULTS ON LIKELIHOOD OF SURVIVAL AND REHOSPITALISATION RATES1

47% increase of likelihood of survival within the 1st year for patients with chronic heart failure, compared to standard follow-up (OR 1.47)1

1. Herold R, et al. Telemedical care and monitoring for patients with chronic heart failure has a positive effect on survival. Health Services Research.

705387_AL_CCC_AP_ENGLISH_A5_EXE.indd 1 22/09/2017 17:59

“In today’s interconnected world… a health threat anywhere is a health threat everywhere.”

Prepare. Prevent. Protect.Specialty products that address serious public health threats.

Emergent BioSolutions is a global specialty life sciences company. Through our work, we envision protecting & enhancing 50 million lives with our products by 2025.

– Centers for Disease Control and Prevention

BACK AT HOMEnever alone

© W

este

nd61

HH

C-00

8

www.chroniccareconnect.com

Telemonitoring based on criteria pre-de�ned with

the referral physician

Personalised support from quali�ed nurses who are speci�cally

trained in managing care plans and treatment

of the disease

Alerts generated by tracking algorithms,

individually managed by quali�ed

professionals

A REMOTE MONITORING SOLUTION TO SUPPORT YOUR PATIENTS WITH CHRONIC DISEASES

PROVEN RESULTS ON LIKELIHOOD OF SURVIVAL AND REHOSPITALISATION RATES1

47% increase of likelihood of survival within the 1st year for patients with chronic heart failure, compared to standard follow-up (OR 1.47)1

1. Herold R, et al. Telemedical care and monitoring for patients with chronic heart failure has a positive effect on survival. Health Services Research.

705387_AL_CCC_AP_ENGLISH_A5_EXE.indd 1 22/09/2017 17:59

“In today’s interconnected world… a health threat anywhere is a health threat everywhere.”

Prepare. Prevent. Protect.Specialty products that address serious public health threats.

Emergent BioSolutions is a global specialty life sciences company. Through our work, we envision protecting & enhancing 50 million lives with our products by 2025.

– Centers for Disease Control and Prevention

ABOUT POLITICO is a global nonpartisan politics and policy news organization, headquartered in Washington, DC. In April 2015, a European edition of the publication launched through a joint venture with the leading digital publisher in Europe, Axel Springer. Based in Brussels, POLITICO covers the politics, policy and personalities of the European Union. The publication also has reporting assets in key capitals across Europe, making it the first publication to truly connect the dots between the Continent’s biggest power players. Its journalism lives online at POLITICO.eu; in print via a weekly newspaper distributed in Brussels, Berlin, Paris, London and Luxembourg; and through newsmaking events.

Editorial:editorial@politico.eu

Print subscriptions:subscriptions@politico.eu+32 2 540 90 98

PRO subscriptions:pro@politico.eu+32 2 548 15 20

Sponsorship & advertisement: sales@politico.eu+32 2 540 90 66/ 73/ 75

Events:events@politico.eu

Strategy & Marketing:smg@politico.eu Follow us on Twitter:@POLITICOEurope

@EventsPOLITICO

ABOUT Founded in 1998, Le Temps is French-speaking Switzerland's leading media of reference. Flying its flag across a variety of media, always with the same insistence on quality and editorial independence, it has become an essential source of information for opinion leaders and deci-sion-makers alike. Its editorial formula comprises four key areas: Politics, Economy & Finance, Culture and Lifestyle.

Editorial: info@letemps.ch +41 21 331 78 00

Subscriptions:abos@letemps.ch +41 848 48 48 05

Advertisement:www.letemps.ch/publt_publicite@admeira.ch+41 58 909 98 21

Events and Marketing:marketing@letemps.ch Follow us on Twitter:@letemps Follow us on Facebook:www.facebook.com/letemps.ch

Follow us on Youtube:www.youtube.com/letemps Follow us on Instagram:@letemps.ch

NOTES

Send us your feedback and receive updates on next year’s Health Care Summit program and sponsorship opportunities.

Contact: events@politico.eu

ASSESSING THE PROMISE OF PREVENTIVE MEDICINE IN HEALTH CARE REFORM

OCTOBER 9, 2018

GENOMICS

PREVENTION PROGRAMS

PERSONALIZED MEDICINE

VACCINES

PREDICTIVE MEDICINE

ANTIMICROBIAL RESISTANCE